Company Filing History:
2 out of 2,343 
2 out of 2,119 
2 out of 1,415 
Years Active: 2017-2022
Title: Innovations of Nicholas Kanaan
Introduction
Nicholas Kanaan is an accomplished inventor based in Grand Rapids, MI (US). He holds a total of 4 patents that focus on groundbreaking advancements in the treatment of neurodegenerative diseases and movement disorders. His work has significant implications for improving the quality of life for individuals suffering from these conditions.
Latest Patents
One of Kanaan's latest patents is titled "Sprr1A as a genetic target for treating neurodegenerative diseases." This invention relates to the prevention and treatment of neurodegenerative diseases by administering compositions that increase the activity of a small proline-rich repeat 1 A protein (Sprr1A) to the brain. The compositions may include a nucleic acid molecule encoding a Sprr1A protein or a biologically-active portion thereof. The neurodegenerative diseases targeted by this invention include Parkinson's Disease, Alzheimer's disease, amyotrophic lateral sclerosis, and traumatic brain injury.
Another significant patent is "Nurr1 as a genetic target for treating levodopa-induced dyskinesias in Parkinson's disease." This patent discloses methods of treating movement disorders by reducing the activity of Nurr1. These methods are particularly applicable to subjects suffering from Parkinson's disease who have developed levodopa-induced dyskinesia (LID) or are at risk of developing LID. The invention outlines a method for treating a movement disorder in a subject by administering a therapeutically effective amount of a composition that reduces the activity of a nuclear receptor related 1 protein (Nurr1).
Career Highlights
Kanaan has made significant contributions to the field of medical research through his innovative patents. His work has been recognized for its potential to transform treatment approaches for neurodegenerative diseases and movement disorders.
Collaborations
Throughout his career, Kanaan has collaborated with notable professionals in the field, including Scott Thomas Brady and Lester I Binder. These collaborations have further enhanced the impact of his research and inventions.
Conclusion
Nicholas Kanaan's contributions to the field of medical research through his patents demonstrate his commitment to advancing treatment options for neurodegenerative diseases and movement disorders. His innovative approaches have the potential to significantly improve patient outcomes and enhance the understanding of these complex conditions.